Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure

被引:51
作者
Dereure, J
Thanh, HD
Lavabre-Bertrand, T
Cartron, G
Bastides, F
Richard-Lenoble, D
Dedet, JP
机构
[1] Univ Montpellier I, Fac Med, Lab Parasitol Mycol, F-34090 Montpellier, France
[2] Univ Montpellier I, Fac Med, Ctr Natl Reference Leishmania, F-34090 Montpellier, France
[3] Ctr Hosp Univ, Hop Bretonneau, Serv Parasitol Mycol Med Trop, Tours, France
[4] Fac Med Montpellier, Histol Lab, Nimes, France
[5] Ctr Hosp Univ, Hop Bretonneau, Serv Oncol, Tours, France
[6] Ctr Hosp Univ, Hop Bretonneau, Serv Malad Infect, Tours, France
关键词
Leishmania; visceral leishmaniasis; survival; lymphoma; pregnancy; lymph node;
D O I
10.1016/S0163-4453(03)00002-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Visceral. leishmaniasis (VL) is generally associated with severe immunodeficiency (AIDS; renal, liver, and heart transplantations; haemopoietic malignancies). More rarely it can be related to an immunotolerence status such as pregnancy. Various observations report the development of leishmaniasis several months or even years after exposure to the parasite. Relapses occur rarely in patients not known to be immunocompromised, but are common after incomplete treatment. They are frequent in patients with Leishmania/HIV co-infection. Asymptomatic phases and relapses suggest that parasite can exist in the tissues for a long time before and/or after clinical onset of the disease. The mechanisms of onset of clinical leishmaniasis following exposure and infestation are highly relevant to understanding the pathology of the disease. The survival of Leishmania parasite between infection and disease or after cure is a very important issue for clinicians and epidemiologists. We describe two cases of VL occurring in a patient with lymphoma and in a pregnant woman. In both cases, parasites remained present in the lymph nodes after clinical cure. (C) 2003 The British Infection Society. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:77 / 81
页数:5
相关论文
共 28 条
[1]  
ANTOINE JC, 1992, LEISHMANIOSES, P41
[2]   THE CHARACTERIZATION OF LEISHMANIA FROM PATIENTS WITH LYMPHADENOPATHY IN SHIRAZ, IRAN [J].
ARDEHALI, S ;
SADEGHIHASSANABADI, A ;
MOADDEB, A ;
ABDOLLAHI, B ;
MALEKHOSSEINI, Z ;
EVANS, DA .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (04) :370-371
[3]   KALA-AZAR OF LONGSTANDING EVOLUTION IN AN ASPLENIC PATIENT [J].
BADA, JL ;
ARDERIU, A ;
GIMENEZ, J ;
GOMEZACHA, JA .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1979, 73 (03) :347-348
[4]  
BADARO R, 1986, LANCET, V1, P647
[5]  
BENHAMOU E, 1955, PRESSE MED, V63, P1778
[6]   Fibroblasts as host cells in latent leishmaniosis [J].
Bogdan, C ;
Donhauser, N ;
Döring, R ;
Röllinghoff, M ;
Diefenbach, A ;
Rittig, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (12) :2121-2129
[7]   IS LEISHMANIASIS EVER CURED [J].
DEROSSELL, RA ;
DEDURAN, RD ;
ROSSELL, O ;
RODRIGUEZ, AM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (03) :251-253
[8]   Visceral leishmaniasis in three children with leukemia [J].
DiCataldo, A ;
LoNigro, L ;
Marino, S ;
Schiliro, G .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (10) :916-918
[9]  
GASTEBLED G, 1973, J GYNECOL OBST BIO R, V2, P1067
[10]  
GUILLAUD V, 1991, VENEREOLOGY, V118, P850